Literature DB >> 26288356

Tumor Ulceration Does Not Fully Explain Sex Disparities in Melanoma Survival among Adolescents and Young Adults.

Theresa H M Keegan1, Susan M Swetter2, Li Tao3, John B Sunwoo4, Christina A Clarke5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26288356     DOI： 10.1038/jid.2015.325

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  14 in total

1.  The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.

Authors:  Donatus U Ekwueme; Gery P Guy; Chunyu Li; Sun Hee Rim; Pratibha Parelkar; Suephy C Chen
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

2.  Melanoma survival disadvantage in young, non-Hispanic white males compared with females.

Authors:  Christina S Gamba; Christina A Clarke; Theresa H M Keegan; Li Tao; Susan M Swetter
Journal:  JAMA Dermatol       Date:  2013-08       Impact factor: 10.282

3.  Sex differences in melanoma survival are not related to mitotic rate of the primary tumor.

Authors:  Arjen Joosse; Augustinus P T van der Ploeg; Lauren E Haydu; Tamar E C Nijsten; Esther de Vries; Richard A Scolyer; Alexander M M Eggermont; Jan Willem W Coebergh; John F Thompson
Journal:  Ann Surg Oncol       Date:  2014-11-19       Impact factor: 5.344

4.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Authors:  C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

5.  Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials.

Authors:  Arjen Joosse; Sandra Collette; Stefan Suciu; Tamar Nijsten; Ferdy Lejeune; Ulrich R Kleeberg; Jan Willem W Coebergh; Alexander M M Eggermont; Esther de Vries
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

Review 6.  Sex disparities in melanoma outcomes: the role of biology.

Authors:  Adi Nosrati; Maria L Wei
Journal:  Arch Biochem Biophys       Date:  2014-07-21       Impact factor: 4.013

7.  The influence of marital status on stage at diagnosis and survival of older persons with melanoma.

Authors:  Carlos A Reyes Ortiz; Jean L Freeman; Yong-Fang Kuo; James S Goodwin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-08       Impact factor: 6.053

8.  The age-specific effect modification of male sex for ulcerated cutaneous melanoma.

Authors:  Blakely S Richardson; William F Anderson; Jill S Barnholtz-Sloan; Margaret A Tucker; Meg R Gerstenblith
Journal:  JAMA Dermatol       Date:  2014-05       Impact factor: 10.282

9.  Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.

Authors:  Arjen Joosse; Sandra Collette; Stefan Suciu; Tamar Nijsten; Poulam M Patel; Ulrich Keilholz; Alexander M M Eggermont; Jan Willem W Coebergh; Esther de Vries
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

10.  Xist RNA is a potent suppressor of hematologic cancer in mice.

Authors:  Eda Yildirim; James E Kirby; Diane E Brown; Francois E Mercier; Ruslan I Sadreyev; David T Scadden; Jeannie T Lee
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.